No association was observed between cfPWV or AIx@75 and disease duration, APS type (PAPS or SLE-APS), type of thrombotic events (arterial or venous), recurrent events, double or triple aPL positivity, aGAPSS or aGAPSS-CVD, disease activity (SLEDAI-2K), disease damage (SDI) and disease-related medications (Table 4, Supplementary Tables S4 and S5, available at Rheumatology online). Here, FASLG is linked to systemic lupus erythematosus.